查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1831840

2025 年至 2033 年生物外科市场报告（按产品、来源、应用、最终用户和地区）

Biosurgery Market Report by Product, Source, Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球生物外科市场规模达148亿美元。展望未来， IMARC Group预计到2033年，市场规模将达到251亿美元，2025-2033年期间的复合年增长率（CAGR）为5.76%。北美是生物外科最大的区域市场，这得益于其先进的医疗基础设施、对研发活动的大量投入，以及推动创新和扩张的领导者。此外，外科手术的增加、医疗器械技术的进步以及对复杂手术中有效伤口管理的需求不断增长，正在改善全球患者的手术效果并缩短患者的康復时间。

随着医疗技术的进步和医疗保健需求的不断变化，生物外科市场正在发生巨大的变化。生物外科技术日益增长的前景和复杂性，正在促进医疗部门和学术中心之间的更多互动。学术机构和研究机构在研究新的生物材料、创造新的手术方法以及透过临床试验测试新产品的有效性方面占据着中心地位。这种合作环境正在推动创新生物外科解决方案的快速发展，因为製造商和科学家正在合作更快地将新产品推向市场。此外，学术中心在培训未来的外科医生了解生物外科的优势和应用方面发挥着积极作用。随着越来越多的医疗保健专业人员接受生物衍生产品处理的培训，这些产品在临床实务中的应用和接受度也不断提高。合作研究也正在加深对复杂生物机制的理解，并将有用的见解应用于开发改进的生物外科解决方案，使不同的患者群体受益。

生物外科市场趋势：

生物外科产品的技术进步

技术发展对生物外科市场的快速成长贡献巨大。生物材料的持续改进正在提高止血钳、黏合剂和组织工程产品等产品的效率。各公司正瞄准更有效率、生物相容性和永续性的外科产品。例如，促进伤口更快癒合和增强组织再生的生物活性材料的进步正在彻底改变这一领域。此外，3D列印技术的发展促进了个人化植入物和手术器械的生产，为更有效率、更客製化的外科干预铺平了道路。这些发展不仅提高了手术效果，也使生物外科产品更容易取得且价格更实惠。随着新技术的出现，生物外科解决方案的范围正在扩大，能够满足更多类型的手术需求，并促进改善各医学专业的病患照护。 3D Systems宣布，与瑞士巴塞尔大学医院合作，利用其独家的即时医疗增材製造解决方案，打造全球首款符合医疗器材法规 (MDR) 的3D列印PEEK脸部植入物。 Florian Thieringer教授和Neha Sharma博士及其生物医学工程师团队，利用3D Systems的技术和製造知识，高效地创建并生产了一款客製化设备，以满足患者的特定需求。该植入物于2025年3月18日在医院成功完成手术。

微创手术需求增加

对微创手术日益增长的需求是市场成长的根本动力之一。由于医护人员和患者都希望最大限度地缩短传统开放性手术的恢復时间和风险，越来越多的微创手术被采用。在大多数情况下，这些手术切口更小，对周围组织的创伤更小，失血量更少，从而缩短了恢復期并减少了併发症。包括止血钳和生物黏合剂在内的生物外科器械是这些手术的一部分，因为它们有助于更好地闭合组织并精确控制出血。外科医师也会在微创手术中使用生物材料来促进伤口癒合并预防感染。随着各专业领域微创手术的趋势日益明显，对支持这些手术的生物外科解决方案的需求也不断增长，这进一步推动了市场的成长。 IMARCIMARC Group预测，到2033年，全球微创手术市场规模预计将达到949亿美元。

全球人口老化

全球人口老化在推动生物外科市场发展方面发挥巨大作用。根据世界卫生组织 (WHO) 在 2025 年发表的一篇文章，预计到 2030 年，60 岁及以上人口数量将增至 14 亿。随着年龄的增长，人们往往会患上各种需要手术的疾病，包括关节置换、心血管手术和骨科手术。老年患者的恢復机制通常较慢，更容易出现手术和术后併发症。组织工程移植物、伤口癒合产品和生物黏合剂等生物外科设备正在解决这些问题，这些设备有助于加快患者恢復速度，最大限度地降低感染风险，并优化组织再生。其次，由于老年患者患有更多需要持续医疗照护的慢性疾病，对复杂的生物外科解决方案的需求也不断增加。因此，全球老年人口正在推动市场成长，因为医疗保健系统越来越多地采用先进技术来改善手术效果并缩短老年患者的恢復期。

生物外科市场成长动力：

医疗成本不断增加，对先进外科手术解决方案的敏感度也不断提高

全球医疗保健支出不断增长，生物外科产品等先进外科解决方案的优势日益凸显。如今，医护人员和患者都更加意识到生物工程外科产品相较于传统合成产品的优势，例如更短的癒合时间、更少的併发症以及更好的生物相容性，这些对于最大程度地提高手术效果至关重要。医疗保健系统，尤其是已开发国家的医疗保健系统，目前正在大力投资此类先进的解决方案，以提高护理品质并控制长期康復和併发症的成本。随着越来越多的医学专家采用先进的外科手术方法，生物活性敷料、组织移植物和可生物降解缝线等生物外科器械正成为各种手术的重要组成部分。

慢性病和外科手术发生率不断上升

糖尿病、心血管疾病和肥胖等慢性疾病的发生率不断上升，推动着市场的成长。大多数慢性疾病都可能导致需要手术治疗的疾病，例如糖尿病溃疡、血管外科手术和关节置换。随着这些疾病的日益普遍，对能够加快康復速度并减少併发症的新型外科产品的需求也日益增长。生物外科产品，例如用于伤口护理的生物解决方案、组织修復解决方案和止血剂，在外科手术中的应用日益广泛，旨在改善慢性患者的治疗效果。例如，生物移植物和敷料在糖尿病患者难以癒合的慢性复杂伤口的癒合过程中发挥着至关重要的作用。随着全球慢性病负担的日益加重，对生物外科产品的需求也日益增长，使得这些产品成为当代外科手术不可或缺的一部分。

扩大新兴市场的医疗保健覆盖率

新兴经济体医疗保健服务可近性的提升正在推动市场成长。发展中国家医疗基础设施的改善和先进医疗技术的普及，持续刺激对生物外科产品的需求。这些国家在骨科、心血管和创伤护理领域的手术率不断上升，这推动了生物外科产品的使用。随着民众获得优质医疗服务的管道日益畅通，能够改善手术效果的生物外科产品的应用也日益广泛。此外，许多政府和医疗体係正在投资旨在提升外科护理水平、最大程度降低医疗併发症发生率的项目，从而进一步推动了对生物外科解决方案的需求。

生物外科市场细分：

按产品分类：

  • 骨移植替代品
  • 软组织附着
  • 止血剂
  • 外科密封剂和黏合剂
  • 防沾黏屏障
  • 钉合线加固

骨移植替代品占大部分市场份额

骨移植替代品是骨移植的重要替代方案。这些替代品在许多外科手术中发挥关键作用，支持骨科、创伤、脊椎外科和牙科应用中的骨再生和修復。它们旨在透过促进骨骼发育并取代需要从患者自身取骨的传统自体移植，最大限度地降低供体部位发病率和感染风险。此外，骨骼和关节问题的日益增加、对微创手术的需求以及生物材料技术的发展也推动了骨移植替代品的扩张。新型合成和复合移植材料的研发也推动了这个细分市场的成长，这些材料的研发具有更佳的骨传导和骨诱导特性。例如，2023年5月23日，专注于利用先进的细胞和自体技术改善手术效果的Royal Biologics, Inc.推出了BIO-REIGN 3D。这款创新骨移植替代品首次使用了天然高交联碳水化合物聚合物。它旨在增强骨移植程序，这项专有技术与 Royal Biologics 对 Molecular Matrix 的专利 Osteo-P BGS 技术的授权协议一起推出。

依来源分类：

  • 天然/生物製品
  • 合成产品

天然/生物製剂产品占据产业最大份额

根据生物外科市场概况，天然/生物製剂因其有效的癒合特性和生物相容性占据了最大的市场份额。这些产品源自于人体天然存在的物质或其他生物来源，包括纤维蛋白封闭剂、胶原基质和壳聚醣溶液。此外，天然/生物製剂能够模拟自然生理过程，显着降低排斥反应和不良反应的风险，使其成为外科手术的首选。此外，生物技术的进步提高了这些材料的安全性和有效性，进一步巩固了其市场主导地位。因此，微创手术需求的不断增长，加上需要复杂手术的慢性疾病的日益增多，持续推动天然/生物製剂在市场上的成长。

按应用分类：

  • 骨科手术
  • 一般外科
  • 神经外科
  • 心血管外科
  • 妇科手术
  • 其他的

神经外科代表着领先的细分市场

神经外科手术复杂且精准度要求极高。此外，生物外科产品（如密封剂、止血剂和防沾黏膜）广泛应用于神经外科手术，用于控制出血、封闭组织并减少术后併发症。此外，脑肿瘤、癫痫和帕金森氏症等神经系统疾病的发生率不断上升，加上神经外科技术的进步，也推动了该领域的需求。此外，微创手术的广泛应用需要高效的生物外科解决方案来改善患者预后，这进一步推动了生物外科市场的成长。生物外科产品的技术创新也推动了这一趋势，旨在改善手术效果并缩短恢復时间。

按最终用户分类：

  • 医院
  • 诊所
  • 其他的

医院在市场上占据明显主导地位

医院提供各种各样的外科手术，这些手术经常使用生物外科产品。这些产品包括止血剂、外科密封剂和黏合剂，对于控制术中和术后出血以及促进组织癒合至关重要。此外，医院处理大量患者和进行复杂手术的能力也增加了对生物外科的需求。此外，外科技术的不断进步和对微创手术日益增长的偏好进一步扩大了生物外科解决方案在医院环境中的应用。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美引领市场，占据最大的生物外科市场份额

该报告还对所有主要区域市场进行了全面分析，包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告指出，北美是生物外科最大的区域市场。

北美凭藉其先进的医疗基础设施、对研发活动的大量投入以及推动创新和扩张的领先企业，成为生物外科市场的领先地区。此外，北美慢性病发病率的上升和老龄化人口的增长也推动了对生物外科产品的需求。根据生物外科市场预测，这些因素，加上有利的政府政策和强劲的微创手术趋势，将继续巩固北美在全球生物外科市场的领先地位。

本报告回答的关键问题：

  • 全球生物外科市场迄今表现如何，未来几年将如何表现？
  • 全球生物外科市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球生物外科市场有何影响？
  • 主要的区域市场有哪些？
  • 哪些国家代表最具吸引力的生物外科市场？
  • 根据产品，市场是如何分類的？
  • 生物外科市场上最有吸引力的产品是什么？
  • 根据来源，市场细分情况如何？
  • 生物外科市场中最具吸引力的来源是什么？
  • 根据应用，市场是如何分類的？
  • 生物外科市场中最具吸引力的应用是什么？
  • 根据最终用户，市场是如何分類的？
  • 生物外科市场中最具吸引力的最终用户是谁？
  • 市场的竞争结构是怎么样的？
  • 全球生物外科市场的主要参与者/公司有哪些？

本报告回答的关键问题：

  • 全球生物外科市场迄今表现如何，未来几年将如何表现？
  • 全球生物外科市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球生物外科市场有何影响？
  • 主要的区域市场有哪些？
  • 哪些国家代表最具吸引力的生物外科市场？
  • 根据产品，市场是如何分類的？
  • 生物外科市场上最有吸引力的产品是什么？
  • 根据来源，市场细分情况如何？
  • 生物外科市场中最具吸引力的来源是什么？
  • 根据应用，市场是如何分類的？
  • 生物外科市场中最具吸引力的应用是什么？
  • 根据最终用户，市场是如何分類的？
  • 生物外科市场中最具吸引力的最终用户是谁？
  • 市场的竞争结构是怎么样的？
  • 全球生物外科市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球生物外科市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 骨移植替代品
  • 软组织附着
  • 止血剂
  • 外科密封剂和黏合剂
  • 防沾黏屏障
  • 钉合线加固

第七章：市场区隔：依来源

  • 天然/生物製品
  • 合成产品

第 8 章：市场区隔：按应用

  • 骨科手术
  • 一般外科
  • 神经外科
  • 心血管外科
  • 妇科手术
  • 其他的

第九章：市场区隔：依最终用户

  • 医院
  • 诊所
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 11 章：SWOT 分析

第 12 章：价值链分析

第 13 章：波特五力分析

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton Dickinson and Company
    • CryoLife Inc.
    • CSL Limited
    • Hemostasis LLC
    • Integra Lifesciences Holdings Corporation
    • Johnson & Johnson
    • Medtronic plc
    • Pfizer Inc.
    • Sanofi SA
    • Smith & Nephew plc
    • Stryker Corporation
    • Surgalign Spine Technologies Inc.
Product Code: SR112025A4522

The global biosurgery market size reached USD 14.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 25.1 Billion by 2033, exhibiting a growth rate (CAGR) of 5.76% during 2025-2033. North America was the largest regional market for biosurgery owing to the advanced healthcare infrastructure, significant investments in research and development (R&D) activities, and the presence of leading players who drive innovation and expansion. Moreover, the increasing surgical procedures, technological advancements in medical devices, and growing demand for effective wound management in complex surgeries is enhancing surgical outcomes and recovery times for patients across the globe.

The market for biosurgery is undergoing immense changes with the advancement of medical technologies and evolving healthcare requirements. The growing promise and complexity of biosurgical technologies are stimulating more interaction between the medical sector and academic centers. Academic institutions and research institutes are taking center stage in investigating new biologic materials, creating new surgical methods, and testing the efficacy of new products through clinical trials. This cooperative setting is developing the swift growth of innovative biosurgical solutions, as manufacturers and scientists collaborate to advance new products to market more quickly. In addition, academic centers play an active role in training future surgeons about the advantages and applications of biosurgery. With increasing numbers of healthcare professionals being trained in the handling of biologically derived products, the uptake and acceptance of these products in clinical practice is also growing. Collaborative research endeavors are also refining the understanding of complicated biological mechanisms, and useful insights are being utilized in developing improved biosurgical solutions that can benefit various patient groups.

Biosurgery Market Trends:

Technological Progress in Biosurgical Products

Technological developments are contributing tremendously to the faster growth of the biosurgery market. Ongoing improvements in biologic materials are increasing the efficiency of products like hemostats, adhesives, and tissue-engineered products. Companies are targeting more efficient, biocompatible, and sustainable surgical products. For instance, advances in bioactive materials that promote faster wound healing and enhance tissue regeneration are revolutionizing the space. In addition, development in 3D printing technology is facilitating the production of personalized implants and surgical instruments, making way for more efficient and tailor-made surgical interventions. These developments not only enhance surgical performance but also make biosurgical products more accessible and affordable. With new technologies coming onto the scene, the scope of biosurgical solutions is increasing, treating more types of surgical requirements and facilitating improved patient care across a variety of medical specialties. 3D Systems revealed that, in partnership with University Hospital Basel (Switzerland), the Company's exclusive point-of-care additive manufacturing solution is utilized to create the world's first 3D-printed PEEK facial implant compliant with Medical Device Regulation (MDR). Prof. Florian Thieringer and Dr. Neha Sharma, along with their team of biomedical engineers, effectively created and produced a tailored device to meet a patient's specific requirement utilizing 3D Systems technology and manufacturing knowledge. This implant was utilized in a successful operation finished at the hospital on March 18, 2025.

Increased Demand for Minimally Invasive Procedures

The heightened need for minimally invasive procedures is one of the fundamental growth drivers in the market. As medical practitioners and patients aim to minimize the recovery time and risks involved with conventional open surgeries, more minimally invasive procedures are being performed. These surgeries, in most cases, entail smaller cuts, less trauma to the tissues around them, and less blood loss, resulting in shorter recovery periods and fewer complications. Biosurgical items, including hemostats and biologic adhesives, are part of these procedures as they facilitate better tissue sealing and bleeding control with accuracy. Surgeons are also employing biologic materials for better wound healing and the prevention of chances of infection in minimally invasive procedures. With the trend toward minimally invasive procedures in all specialties, the need for biosurgical solutions that enable these procedures is increasing, further fueling the market growth. IMARC Group predicts that the global minimally invasive surgery market is anticipated to reach USD 94.9 Billion by 2033.

Aging Global Population

The aging world population is playing a huge role in driving the biosurgery market. As per an article published by the World Health Organization (WHO) in 2025, the number of people aged 60 and above is anticipated to increase to 1.4 billion by 2030. As individuals grow older, they tend to develop a variety of ailments that call for surgeries, including joint replacements, cardiovascular procedures, and orthopedic procedures. Elderly patients generally possess slower recovery mechanisms and are more prone to surgical and post-surgical complications. These issues are being dealt with by biosurgical devices like tissue-engineered grafts, wound healing products, and biologic adhesives that are facilitating quicker recovery, minimizing the risk of infection, and optimizing tissue regeneration. Second, as older patients have more chronic diseases that necessitate continuous medical care, the need for sophisticated biosurgical solutions is also on the increase. The elderly population worldwide is therefore fueling the market growth since healthcare systems are increasingly embracing advanced technologies to enhance surgical outcomes and reduce recovery periods for older patients.

Biosurgery Market Growth Drivers:

Increasing Healthcare Costs and Sensitivity to Advanced Surgical Solutions

Health care spending is rising globally, and advanced surgical solutions, such as biosurgical products, are increasingly recognized as having advantages. Both healthcare professionals and patients are more aware today about the benefits that biologically engineered surgical products provide over conventional synthetic ones. These include lower healing times, fewer complications, and better biocompatibility, which are important for maximizing surgical outcomes. Healthcare systems, especially those in the developed world, are now investing heavily in such sophisticated solutions to enhance care quality and contain the costs of long-term recovery and complications. With more medical specialists adopting sophisticated surgical methods, biosurgical devices like bioactive dressings, tissue grafts, and biodegradable sutures are becoming part and parcel of a variety of procedures.

Increasing Incidence of Chronic Diseases and Surgical Surgeries

The increasing incidence of chronic diseases, including diabetes, cardiovascular disease, and obesity, is propelling the market growth. Most chronic diseases result in conditions that are likely to be treated with surgery, like diabetic ulcers, vascular surgeries, and joint replacements. As these conditions become more prevalent, the demand for novel surgical products that enhance faster recovery and lower complications is increasing. Biosurgical products like biologic solutions for wound care, tissue repair solutions, and hemostatics are finding growing use in surgeries to provide improved patient outcomes for chronic patients. For instance, biologic grafts and dressings play a crucial role in healing chronic, complicated wounds that are slow to heal in diabetic patients. With the growing global burden of chronic disease, the need for biosurgical products is spreading wide, making these products integral parts of contemporary surgical procedures.

Expanding Healthcare Access in Emerging Markets

Increased access to healthcare in emerging economies is bolstering the market growth. The developing world's improvement in healthcare infrastructure and access to sophisticated medical technology continues to catalyze the demand for biosurgical products. These nations are observing increased rates of surgeries in orthopedic, cardiovascular, and trauma care segments, which are driving the use of biosurgery products. As the populations become increasingly accessible to quality healthcare, biosurgical products with improved surgical outcomes are finding increased applications. Furthermore, numerous governments and healthcare systems are investing in projects aimed at enhancing surgical care and minimizing the incidence of medical complications, thus creating additional demand for biologically derived surgical solutions.

Biosurgery Market Segmentation:

Breakup by Product:

  • Bone-Graft Substitutes
  • Soft-Tissue Attachments
  • Hemostatic Agents
  • Surgical Sealants and Adhesives
  • Adhesion Barriers
  • Staple Line Reinforcement

Bone-graft substitutes account for the majority of the market share

Bone-graft substitutes are crucial alternatives to bone grafting. These stand-ins play a critical role in many surgical operations, supporting bone regeneration and repair in orthopedics, trauma, spine surgery, and dentistry applications. They are intended to minimize the risk of donor site morbidity and infection by promoting bone development and replacing conventional autografts, which require removing bone from the patient's own body. Furthermore, the expansion is driven by the increasing frequency of bone and joint problems, the need for less intrusive operations, and developments in biomaterial technology. The growth of this market segment is also fueled by the creation of novel synthetic and composite grafts with improved osteoconductive and osteoinductive qualities. For instance, on 23 May 2023, Royal Biologics, Inc., a company focused on advanced cellular and autologous technologies for improved surgical outcomes, unveiled BIO-REIGN 3D. This innovative bone graft substitute is the first to use a natural hyper-crosslinked carbohydrate polymer. It is designed to enhance bone grafting procedures, and this proprietary technology is introduced alongside Royal Biologics' licensing agreement for Molecular Matrix's patented Osteo-P BGS technology.

Breakup by Source:

  • Natural/Biologics Products
  • Synthetic Products

Natural/biologics products hold the largest share of the industry

According to the biosurgery market overview, natural/biologics represent the largest segment due to their effective healing properties and biocompatibility. These products, derived from substances that are naturally present in the human body or other biological sources, include fibrin sealants, collagen-based matrices, and chitosan-based solutions. Additionally, natural/biologics product's ability to mimic natural physiological processes significantly reduces the risk of rejection and adverse reactions, making them highly preferred in surgical procedures. Moreover, market dominance is further supported by advancements in biotechnology that enhance the safety and efficacy of these materials. Consequently, the increasing demand for minimally invasive surgeries, coupled with the growing prevalence of chronic diseases requiring complex surgeries, continues to drive the growth of natural/biologics products in the market.

Breakup by Application:

  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Gynecological Surgery
  • Others

Neurological surgery represents the leading market segment

Neurological surgeries are complex and require critical precision. Additionally, biosurgery products, such as sealants, hemostatic agents, and adhesion barriers, are extensively used in neurological procedures to manage bleeding, seal tissues, and reduce post-operative complications. Moreover, the rising prevalence of neurological disorders, such as brain tumors, epilepsy, and Parkinson's disease, coupled with advancements in neurosurgical techniques are escalating the demand in this segment. Besides, the widespread adoption of minimally invasive (MI) surgeries, which require highly effective biosurgical solutions to enhance patient outcomes is further driving the biosurgery market growth. This trend is supported by technological innovations in biosurgery products, aimed at improving surgical outcomes and reducing recovery times.

Breakup by End User:

  • Hospitals
  • Clinics
  • Others

Hospital exhibits a clear dominance in the market

Hospitals offer a wide array of surgical procedures that frequently utilize biosurgical products. These products, which include hemostatic agents, surgical sealants, and adhesives, are integral in managing intraoperative and postoperative bleeding and promoting tissue healing. Additionally, hospitals' capacity to handle high patient volumes and conduct complex surgeries increases biosurgery demand. Additionally, the constant advancements in surgical techniques and the increasing preference for minimally invasive surgeries further amplify the utilization of biosurgical solutions in hospital settings.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest biosurgery market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for biosurgery.

North America is the leading region due to the advanced healthcare infrastructure, significant investments in research and development (R&D) activities, and the presence of leading players who drive innovation and expansion. Additionally, the increasing prevalence of chronic diseases and the growing elderly population in North America contribute to a higher demand for biosurgical products. According to the biosurgery market forecast, these factors, combined with favorable government policies and a strong trend toward minimally invasive surgeries, will continue to strengthen North America's leading position in the global biosurgery market.

Competitive Landscape:

  • The biosurgery market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the industry include B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, CryoLife Inc., CSL Limited, Hemostasis LLC, Integra Lifesciences Holdings Corporation, Johnson & Johnson, Medtronic plc, Pfizer Inc., Sanofi S.A., Smith & Nephew plc, Stryker Corporation and Surgalign Spine Technologies Inc.
  • At present, biosurgery market players are actively enhancing market growth through a combination of strategic collaborations, innovative product launches, and expansions into new geographical markets. These companies invest heavily in research and development (R&D) to introduce advanced products that meet the increasing demands of minimally invasive surgeries and improved wound care. Additionally, market players are focusing on obtaining regulatory approvals across different regions, which helps in expanding their global footprint and accessing new markets. These strategies collectively contribute to the robust growth and resilience of the biosurgery market. For instance, in 2023, AROA Biosurgery Ltd. revealed the release of a new retrospective pilot case series that explores the use of Myriad Matrix and Myriad Morcells in the surgical treatment of contaminated volumetric soft tissue defects. It reviewed 13 complex traumatic wounds in 10 patients at a single facility. The study reported an average time of 23.4+-9.2 days for achieving soft tissue coverage and fill, with a median of one product application and no complications among participants. Moreover, the research focused on injuries from motor vehicle accidents, abdominal dehiscence after hernia repair, Fournier's Gangrene, compartment syndrome, and pressure injuries at a US Level 1 trauma center. It found that the Myriad products facilitated effective soft tissue formation with no reported complications, reinforcing the utility of AROA ECM products in trauma care.

Key Questions Answered in This Report:

  • How has the global biosurgery market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global biosurgery market?
  • What is the impact of each driver, restraint, and opportunity on the global biosurgery market?
  • What are the key regional markets?
  • Which countries represent the most attractive biosurgery market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the biosurgery market?
  • What is the breakup of the market based on the source?
  • Which is the most attractive source in the biosurgery market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the biosurgery market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the biosurgery market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global biosurgery market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biosurgery Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Bone-Graft Substitutes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Soft-Tissue Attachments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hemostatic Agents
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Surgical Sealants and Adhesives
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Adhesion Barriers
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Staple Line Reinforcement
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Source

  • 7.1 Natural/Biologics Products
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Synthetic Products
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Orthopedic Surgery
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 General Surgery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Neurological Surgery
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cardiovascular Surgery
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Gynecological Surgery
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 B. Braun Melsungen AG
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 SWOT Analysis
    • 15.3.2 Baxter International Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Becton Dickinson and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 CryoLife Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 CSL Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Hemostasis LLC
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Integra Lifesciences Holdings Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Johnson & Johnson
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Medtronic plc
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Sanofi S.A.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Smith & Nephew plc
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Stryker Corporation
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Surgalign Spine Technologies Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials

List of Figures

  • Figure 1: Global: Biosurgery Market: Major Drivers and Challenges
  • Figure 2: Global: Biosurgery Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Biosurgery Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Biosurgery Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Biosurgery Market: Breakup by Source (in %), 2024
  • Figure 6: Global: Biosurgery Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Biosurgery Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Biosurgery Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Biosurgery (Bone-Graft Substitutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Biosurgery (Bone-Graft Substitutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Biosurgery (Soft-Tissue Attachments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Biosurgery (Soft-Tissue Attachments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Biosurgery (Hemostatic Agents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Biosurgery (Hemostatic Agents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Biosurgery (Surgical Sealants and Adhesives) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Biosurgery (Surgical Sealants and Adhesives) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Biosurgery (Adhesion Barriers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Biosurgery (Adhesion Barriers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Biosurgery (Staple Line Reinforcement) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Biosurgery (Staple Line Reinforcement) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Biosurgery (Natural/Biologics Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Biosurgery (Natural/Biologics Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Biosurgery (Synthetic Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Biosurgery (Synthetic Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Biosurgery (Orthopedic Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Biosurgery (Orthopedic Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Biosurgery (General Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Biosurgery (General Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Biosurgery (Neurological Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Biosurgery (Neurological Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Biosurgery (Cardiovascular Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Biosurgery (Cardiovascular Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Biosurgery (Gynecological Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Biosurgery (Gynecological Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Biosurgery (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Biosurgery (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Biosurgery (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Biosurgery (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Biosurgery (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Biosurgery (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Biosurgery (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Biosurgery (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: North America: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: North America: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: United States: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: United States: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Canada: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Canada: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Asia-Pacific: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Asia-Pacific: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: China: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: China: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Japan: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Japan: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: India: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: India: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: South Korea: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: South Korea: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Australia: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Australia: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Indonesia: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Indonesia: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Others: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Others: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Europe: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Europe: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Germany: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Germany: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: France: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: France: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: United Kingdom: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: United Kingdom: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Italy: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Italy: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Spain: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Spain: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Russia: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Russia: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Others: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Others: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Latin America: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Latin America: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Brazil: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Brazil: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Mexico: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Mexico: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Others: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Others: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Middle East and Africa: Biosurgery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Middle East and Africa: Biosurgery Market: Breakup by Country (in %), 2024
  • Figure 91: Middle East and Africa: Biosurgery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 92: Global: Biosurgery Industry: SWOT Analysis
  • Figure 93: Global: Biosurgery Industry: Value Chain Analysis
  • Figure 94: Global: Biosurgery Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biosurgery Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Biosurgery Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Biosurgery Market Forecast: Breakup by Source (in Million USD), 2025-2033
  • Table 4: Global: Biosurgery Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Biosurgery Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Biosurgery Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Biosurgery Market: Competitive Structure
  • Table 8: Global: Biosurgery Market: Key Players